Inventor · disambiguated record
Zhihao Wu
Also filed as: WU ZHIHAO
9 granted patents·19 pending applications·23 citations·filing 2018–2024
82Inventor score
Files withHUMMINGBIRD BIOSCIENCE PTE LTD8ELPISCIENCE SUZHOU BIOPHARMA LTD6HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD6BIO THERA SOLUTIONS LTD3MEMORIAL SLOAN KETTERING CANCER CENTER3
Top patents by PatentIndex Score
28 records- 0191US10633456B1Vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Granted Apr 28, 2020·14 cites·25 claims
- 0289US10662241B1HER3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Granted May 26, 2020·6 cites·25 claims
- 0385US11555072B2A33 antibody compositions and methods of using the same in radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jan 17, 2023·2 cites·21 claims
- 0483US2025019461A1Her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2024·Application pending·0 cites
- 0581US11208498B2Treatment and prevention of cancer using HER3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2021·Granted Dec 28, 2021·1 cites·16 claims
- 0680US2024092937A1Her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2023·Application pending·0 cites
- 0776US2024158538A1Vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2023·Application pending·0 cites
- 0873US2024327511A1A33 antibody compositions and methods of using the same in radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 0967US11780933B2HER3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2020·Granted Oct 10, 2023·0 cites·13 claims
- 1067US2021024651A1Her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Application pending·0 cites
- 1165US11685789B2CD47 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2022·Granted Jun 27, 2023·0 cites·11 claims
- 1265US2023190649A1Liquid formulation of humanized antibody for treating il-6-mediated diseasesBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 1364US2019300624A1Her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2018·Application pending·0 cites
- 1463US2021380697A1Vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2019·Application pending·0 cites
- 1560US12195554B2Anti-polysialic acid antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Jan 14, 2025·0 cites·20 claims
- 1660US2019300610A1Vista antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2018·Application pending·0 cites
- 1758US11873346B2VISTA antigen-binding moleculesHUMMINGBIRD BIOSCIENCE PTE LTD·Filed 2020·Granted Jan 16, 2024·0 cites·13 claims
- 1858US2022153870A1Treatment and prevention of cancer using her3 antigen-binding moleculesHUMMINGBIRD BIOSCIENCES HOLDINGS LTD·Filed 2021·Application pending·0 cites
- 1952US2022071901A1A liquid formulation of humanized antibody for treating il-6-mediated diseasesBIO THERA SOLUTIONS LTD·Filed 2018·Application pending·0 cites
- 2050US2022298254A1Cd47 antigen-binding moleculesHUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD·Filed 2018·Application pending·0 cites
- 2148US2025313625A1Novel anti-lag3 antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 2248US2025270315A1Novel anti-sirpa antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 2348US2024336686A1Novel multi-specific moleculesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 2446US2023338526A1Anti-cd20 antibody formulation and use of anti-cd20 antibody for treatment of cd20 positive diseasesBIO THERA SOLUTIONS LTD·Filed 2020·Application pending·0 cites
- 2544US2022389067A1Methods of Treating Neurodegenerative Diseases Caused by G4C2 Expansion in C9ORF72UNIV LELAND STANFORD JUNIOR·Filed 2020·Application pending·0 cites
- 2642US2023416394A1Novel conjugate molecules targeting cd39 and tgfbetaELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 2738US2021347908A1Novel anti-sirpa antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 2837US12312410B2Anti-CD39 antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2020·Granted May 27, 2025·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Zhihao Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →